Each patient is different and so is their cancer.
Metsystem’s innovative platform, METscreen, is transforming cancer care by addressing the complexities of metastasis. Using metastasis-targeting technologies and patient-derived organoids, our mission is to predict if and where cancer will spread and identify the most effective treatment for each patient. METscreen is an advanced, functional assay that accounts for intratumor heterogeneity, providing doctors with actionable insights tailored to each unique case.
Contact us directly here and get more info about next generation personalized medicine
By bridging cutting-edge science with clinical application, METscreen, empowers doctors to make precise, informed treatment decisions based on the cancer’s actual response. With broad potential across multiple cancers and therapeutic use cases, our platform is setting a new standard for personalized care in metastatic cancer treatment.
This website uses cookies. By continuing to use this site, you accept our use of cookies. Learn more
